Episode 8: COVID-19 and Cancer Patients

Toni Choueiri joins Brian and Tom to discuss a recent Nature paper regarding the novel HIF inhibitor, casdatifan, and biomarkers of response. 

Ari Hakimi and Lyn Voung from MSKCC join Brian and Tom to discuss their recent Cancer Cell paper exploring the mechanistic impact of TKI-induced hypoxia on immune response in RCC. 

Dr. Brian Goldman speaks with infectious diseases physician Dr. Zain Chagla about omicron, the new coronavirus variant of concern. 

Infectious disease experts Adam Lauring, MD, PhD, and Carlos del Rio, MD, join JAMA Associate Editor Preeti Malani, MD, MSJ, for a discussion of the newly emerged Omicron variant, the potential for a 2021-2022 "twindemic" with flu, and the latest COVID-19 clinical updates. Rec ...

Is an Omicron infection inevitable? Which drugs still work? Is this the last hurrah of the pandemic? This week we have three of the country’s greatest scientific minds teasing apart what Omicron means for our lives now and in the future. Prof Eleanor Riley, Prof Azra Ghani and Pr ...  Show more

Join Dan McCollum as he discusses COVID-19, the disease caused by the novel coronavirus. What are the symptoms of this disease? How is it spread? What personal protective equipment is needed? What are key elements of the history and physical exam? Are there any treatments that he ...  Show more